Therapeutic Goods (Permissible Indications) Determination (No. 1) 2025
5Permissible indications
Start here
Get a plain-English read of 5
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods (Permissible Indications) Determination (No. 1) 2025.
5 Permissible indications
The following indications are covered by this instrument under paragraph 26BF(1)(a) of the Act:
(a) each indication specified in column 2 of the tables in Parts 1 to 17 of Schedule 1; and
(b) each indication specified in column 2 of the tables in Parts 1 to 17 of Schedule 1, as modified by the use of one or more qualifying statements set out in the code tables under one of the following headings:
(i) traditional context qualifiers;
(ii) population qualifiers;
(iii) time of use qualifiers;
(iv) in relation to an indication that is based on TCM evidenceTCM pattern qualifiers.
Note: The population qualifiers set out in the code tables do not include pregnant individuals. Indications relating to pregnancy or pregnant populations are specified in Part 17 of Schedule 1.